Founded in 1972 in Sweden by Professor Lars Leksell and Laurent Leksell, Elekta AB has developed into a leading global medical technology company focused on precision radiation therapy, radiosurgery, and software solutions for the treatment of cancer and brain disorders. Headquartered in Stockholm, the company combines advanced treatment systems, planning and workflow software, and long-standing clinical expertise within an international platform serving hospitals and cancer centers worldwide. Elekta sells in more than 120 countries, operates through more than 40 local offices and distributors, and employs more than 4,500 people globally. In fiscal year 2024/25, the company reported net sales of SEK 18.0 billion, reflecting its established position in specialized oncology technology and clinical care infrastructure.
Updated 2026-03-19